SCHEMBL7710218

SCHEMBL7710218

CCC(c1ccc2c(c1)N=C(N)C(C)O2)N(Cc1ccccc1)C(=O)OC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 1/20 0.33
SLC6A4 P31645 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
NCOR2 Q9Y618 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
POLB P06746 1/20 0.32
HSD17B10 Q99714 1/20 0.32
ALOX5 P09917 1/20 0.32
GPBAR1 Q8TDU6 1/20 0.31
TRPM8 Q7Z2W7 2/20 0.31
BACE1 P56817 4/20 0.31
ABCB1 P08183 1/20 0.31
AKT1 P31749 2/20 0.31
SYK P43405 1/20 0.30
HSD11B1 P28845 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7708180 0.87 HTT (0.34) L3MBTL1ALDH1A1LMNAPOLBTRPM8
SCHEMBL7704961 0.83 HDAC3 (0.33) HTR2CSLC6A4HDAC3HDAC1HDAC2
SCHEMBL5188384 0.81 LMNA (0.31) L3MBTL1ALDH1A1LMNA
SCHEMBL7088859 0.80 PARP1 (0.37) HTR2CSLC6A4HDAC3HDAC1HDAC2
SCHEMBL7704922 0.80 PARP1 (0.48) HDAC3HDAC1HDAC2NCOR2L3MBTL1
SCHEMBL6302740 0.79 HDAC3 (0.43) HTR2CSLC6A4HDAC3HDAC1HDAC2
SCHEMBL5476931 0.77 HDAC1 (0.36) HTR2CSLC6A4HDAC3HDAC1HDAC2
SCHEMBL7704912 0.76 ALDH1A1 (0.45) ALDH1A1LMNAHSD17B10
SCHEMBL7710216 0.75 HSD17B10 (0.35) HTR2CSLC6A4HDAC3HDAC1HDAC2
SCHEMBL5482158 0.73 KDM4E (0.30) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed